ASLAN Pharmaceuticals to Participate in the 2021 Cantor Virtual Global Healthcare Conference
MENLO PARK, Calif., and SINGAPORE, Sept. 22, 2021 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage immunology focused biopharmaceutical company developing innovative...
2019 logo_150x35_jpg.jpg
Novan to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
September 20, 2021 09:00 ET | Novan, Inc.
DURHAM, N.C., Sept. 20, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
Imara to Participate in Upcoming Investor Conferences
September 15, 2021 07:00 ET | Imara, Inc.
BOSTON, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Imara Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapeutics to treat patients...
MNPR Triangle 2.JPG
Monopar Therapeutics to Present at Upcoming Investor Conferences in September
September 09, 2021 08:00 ET | Monopar Therapeutics Inc.
WILMETTE, Ill., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (Nasdaq: MNPR), a clinical-stage biopharmaceutical company primarily focused on developing proprietary therapeutics...
TLC to Present at Cantor Virtual Global Healthcare Conference
September 11, 2020 04:45 ET | TLC
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Sept. 11, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to...
Trevena to Present at the 2019 Cantor Global Healthcare Conference
September 27, 2019 07:00 ET | Trevena Inc.
CHESTERBROOK, Pa., Sept. 27, 2019 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with...
Jounce Therapeutics to Present at the 2018 Cantor Global Healthcare Conference
September 26, 2018 08:00 ET | Jounce Therapeutics, Inc.
CAMBRIDGE, Mass., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer immunotherapies and...
ProQR to Present at Two Investor Conferences in September
September 21, 2017 07:00 ET | ProQR Therapeutics N.V.
LEIDEN, the Netherlands, Sept. 21, 2017 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR) today announced that the Company will present at two investor conferences during the month of...
Cellular Biomedicine Group Inc. Logo
Cellular Biomedicine Group to Present at the Cantor Fitzgerald Global Healthcare Conference
September 14, 2017 08:30 ET | Cellular Biomedicine Group Inc.
SHANGHAI, China and CUPERTINO, Calif., Sept. 14, 2017 (GLOBE NEWSWIRE) -- Cellular Biomedicine Group Inc. (NASDAQ: CBMG) (“CBMG” or the “Company”), a clinical-stage biopharmaceutical firm engaged in...
Innocoll Holdings plc to Present at the Cantor Fitzgerald 2nd Annual Healthcare Conference
July 06, 2016 09:00 ET | Innocoll Holdings plc
ATHLONE, Ireland, July 06, 2016 (GLOBE NEWSWIRE) -- Innocoll Holdings plc (Nasdaq:INNL) a global, specialty pharmaceutical and medical device company with late stage development programs targeting...